Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation

SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection

(2015) Matthieu Blanchet et al.   ANTIVIRAL RESEARCH

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

(2015) Sri Rezeki Hadinegoro et al.   NEW ENGLAND JOURNAL OF MEDICINE

The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response

(2014) Leo Uchida et al.   Scientific Reports

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico

(2014) Gustavo H Dayan et al.   Human Vaccines & Immunotherapeutics

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Lipid Droplet-Binding Protein TIP47 Regulates Hepatitis C Virus RNA Replication through Interaction with the Viral NS5A Protein

(2013) Dorothee A. Vogt et al.   PLoS Pathogens

SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication

(2012) Matthieu Blanchet et al.   ANTIVIRAL RESEARCH

The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif

(2012) Ivo C. Martins et al.   BIOCHEMICAL JOURNAL

Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral Agents

(2012) Andrea D. Olmstead et al.   PLoS Pathogens

Statins Reduce Dengue Virus Production via Decreased Virion Assembly

(2011) Marlén Martínez-Gutierrez et al.   INTERVIROLOGY

Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor

(2011) K. Okamoto et al.   JOURNAL OF GENERAL VIROLOGY

Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is Potassium Ion Dependent and Is Mediated by LD Surface Proteins

(2011) F. A. Carvalho et al.   JOURNAL OF VIROLOGY

Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242

(2011) Antonella Pasquato et al.   VIROLOGY

Antiviral Activity of a Small-Molecule Inhibitor of Arenavirus Glycoprotein Processing by the Cellular Site 1 Protease

(2010) S. Urata et al.   JOURNAL OF VIROLOGY

Rotaviruses Associate with Cellular Lipid Droplet Components To Replicate in Viroplasms, and Compounds Disrupting or Blocking Lipid Droplets Inhibit Viroplasm Formation and Viral Replication

(2010) W. Cheung et al.   JOURNAL OF VIROLOGY

Quantification of Lipid Droplets and Associated Proteins in Cellular Models of Obesity via High-Content/High-Throughput Microscopy and Automated Image Analysis

(2009) Patrick M. McDonough et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Cholesterol biosynthesis modulation regulates dengue viral replication

(2009) Christopher Rothwell et al.   VIROLOGY

Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation

(2009) Marcelo M. Samsa et al.   PLoS Pathogens

Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals

(2008) J. L. Hawkins et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Cholesterol Effectively Blocks Entry of Flavivirus

(2008) C.-J. Lee et al.   JOURNAL OF VIROLOGY